Hillhouse Capital Management - Q2 2018 holdings

$5.87 Billion is the total value of Hillhouse Capital Management's 54 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 0.0% .

 Value Shares↓ Weighting
BGNE  BEIGENE LTDsponsored adr$841,250,000
-8.5%
5,472,2590.0%14.34%
-11.6%
MDLZ  MONDELEZ INTL INCcl a$144,700,000
-1.7%
3,529,2640.0%2.47%
-5.1%
NFLX  NETFLIX INC$103,514,000
+32.5%
264,4500.0%1.76%
+28.0%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$61,425,000
+22.6%
618,3910.0%1.05%
+18.4%
XLRN  ACCELERON PHARMA INC$33,964,000
+24.1%
700,0000.0%0.58%
+19.9%
GTHX  G1 THERAPEUTICS INC$30,397,000
+17.3%
699,4310.0%0.52%
+13.3%
MCO  MOODYS CORP$15,342,000
+5.7%
89,9490.0%0.26%
+2.0%
BRKA  BERKSHIRE HATHAWAY INC DELcl a$14,384,000
-5.7%
510.0%0.24%
-8.9%
SCHW  SCHWAB CHARLES CORP NEW$13,890,000
-2.1%
271,8260.0%0.24%
-5.2%
VRSN  VERISIGN INC$10,404,000
+15.9%
75,7110.0%0.18%
+12.0%
GHG  GREENTREE HOSPITALTY GROUP Lsponsored ads$7,688,000
+41.9%
425,0000.0%0.13%
+36.5%
IDXX  IDEXX LABS INC$7,275,000
+13.9%
33,3800.0%0.12%
+9.7%
SFUN  FANG HLDGS LTDadr$5,820,000
-24.5%
1,500,0000.0%0.10%
-27.2%
SPGI  S&P GLOBAL INC$4,972,000
+6.7%
24,3870.0%0.08%
+3.7%
SLDB  SOLID BIOSCIENCES INC$2,494,000
+375.0%
70,0000.0%0.04%
+377.8%
PTI  PROTEOSTASIS THERAPEUTICS IN$2,416,000
-41.3%
865,9230.0%0.04%
-43.8%
TSRO  TESARO INC$1,650,000
-22.2%
37,1000.0%0.03%
-24.3%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MONDELEZ INTL INC22Q3 201844.4%
JD COM INC19Q2 201980.2%
SOHU COM INC19Q1 201813.4%
58 COM INC18Q3 20187.8%
TAL EDUCATION GROUP18Q2 20194.4%
CTRIP COM INTL LTD17Q2 201728.4%
BEIGENE LTD14Q2 201925.2%
MELCO RESORT ENTERTAINMENT L14Q3 20186.4%
CAMECO CORP14Q4 20172.2%
ENSTAR GROUP LIMITED12Q2 201921.9%

View Hillhouse Capital Management's complete holdings history.

Latest significant ownerships (13-D/G)
Hillhouse Capital Management Q2 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
China Jo-Jo Drugstores Holdings, Inc.February 14, 2023403,3344.7%
TScan Therapeutics, Inc.February 14, 2023? ?
Enfusion, Inc.February 14, 20224,975,1837.6%
Enstar Group LTDJuly 19, 2021? ?
Zoom Video Communications, Inc.February 16, 20212,981,2651.5%
NIO Inc.February 14, 2020? ?
Sea LtdFebruary 14, 20204,300,0002.3%
Uxin LtdFebruary 14, 202021,733,0232.6%
Apellis Pharmaceuticals, Inc.February 14, 20192,098,5813.7%
iQIYI, Inc.February 14, 2019240,191,17411.0%

View Hillhouse Capital Management's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-03-05
13F-NT2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2024-02-14
SC 13G2024-02-14
42024-02-01
32024-01-25
13F-NT2023-11-14
13F-NT2023-08-14

View Hillhouse Capital Management's complete filings history.

Compare quarters

Export Hillhouse Capital Management's holdings